Review Product Marketing Authorisation For Human Use «Tomicinofta».

Original Language Title: Modifica dell'autorizzazione all'immissione in commercio delmedicinale per uso umano «Tomicinofta».

Read the untranslated law here: http://www.gazzettaufficiale.it/atto/serie_generale/caricaArticoloDefault/originario?atto.dataPubblicazioneGazzetta=2015-05-05&atto.codiceRedazionale=15A03270&elenco30giorni=false&atto.tipoProvvedimento=DECRETO

Retrieved April 21, 2015 V&A/772 of authorization determines the transfer of title of the marketing authorisations of the medicinal listed below so far registered in the name of Sooft company Italy S.p.a. (tax number 01624020440) with registered office and tax domicile in Contrada Molino, 17, 63833-Montegiorgio-Fermo (FM).
Medicine TOMICINOFTA.
0.3% # 039571017-AIC Pack «eye drops bottle 5 ml ' to society: Win S.p.a. (tax number 13089440153) with registered office and tax domicile in Via Giovan Battista Oliva, 6/8, 56121-Pisa (PI).
With variation of the name of the medicinal product in OCUPIX Printed The marketing authorisation holder should make the changes, the date of entry into force of determination, referred to in this excerpt, the summary of product characteristics, no later than six months from the same date the package leaflet and labelling.
Inventory disposal Both lots already have products on the date of entry into force of determination, referred to in this excerpt that the batches produced during the period referred to in article 2, paragraph 1, of the same determination, not bearing approved changes can be kept on the market until the expiration date printed on the label of the medicine.
Date of determination: from the day following that of its publication, to decompress, in Gazzetta Ufficiale della Repubblica italiana.